SEC Info - Unitedhealth Group Inc - ‘10-Q’ for 9/30/15

SEC Info℠

Home

My Interests

Help

Please Sign In

We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry.

Unitedhealth Group Inc – ‘10-Q’ for 9/30/15 – ‘EX-101.SCH’

On: Thursday, 11/5/15, at 4:05pm ET · For: 9/30/15 · Accession #: 731766-15-49 · File #: 1-10864

  As Of               Filer                 Filing    For·On·As Docs:Size

11/05/15  Unitedhealth Group Inc            10-Q        9/30/15   84:13M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    867K 
 2: EX-10.2     Material Contract                                   HTML     40K 
 3: EX-10.3     Material Contract                                   HTML     31K 
 4: EX-10.4     Material Contract                                   HTML     75K 
 5: EX-10.5     Material Contract                                   HTML     77K 
 6: EX-10.6     Material Contract                                   HTML     75K 
 7: EX-12.1     Statement re: Computation of Ratios                 HTML     35K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
56: R1          Document and Entity Information Document            HTML     43K 
44: R2          Condensed Consolidated Balance Sheets               HTML    129K 
54: R3          Condensed Consolidated Balance Sheet                HTML     44K 
                (Parenthetical)                                                  
58: R4          Condensed Consolidated Statements of Operations     HTML    101K 
78: R5          Condensed Consolidated Statements of Comprehensive  HTML     66K 
                Income                                                           
46: R6          Condesned Consolidated Statements of Changes in     HTML     90K 
                Equity                                                           
53: R7          Condensed Consolidated Statements of Cash Flows     HTML    118K 
40: R8          Basis of Presentation (Notes)                       HTML     34K 
31: R9          Business Combination (Notes)                        HTML     52K 
79: R10         Goodwill and Other Intangible Assets (Notes)        HTML     64K 
60: R11         Investments (Notes)                                 HTML    255K 
59: R12         Fair Value (Notes)                                  HTML    336K 
65: R13         Medicare Part D Pharmacy Benefits (Notes)           HTML     42K 
66: R14         Medical Costs Reserve Development (Notes)           HTML     38K 
63: R15         Health Insurance Industry Tax (Notes)               HTML     28K 
67: R16         Commercial Paper and Long-Term Debt (Notes)         HTML    240K 
55: R17         Shareholders' Equity (Notes)                        HTML     43K 
57: R18         Share-Based Compensation (Notes)                    HTML    109K 
62: R19         Commitments and Contingencies (Notes)               HTML     39K 
84: R20         Segment Financial Information (Notes)               HTML    326K 
74: R21         Basis of Presentation (Policies)                    HTML     37K 
50: R22         Goodwill and Other Intangible Assets Goodwill and   HTML     28K 
                Other Intangible Assets (Policies)                               
61: R23         Business Combination (Tables)                       HTML     44K 
52: R24         Goodwill and Other Intangible Assets (Tables)       HTML     66K 
24: R25         Investments (Tables)                                HTML    256K 
75: R26         Fair Value (Tables)                                 HTML    339K 
81: R27         Medicare Part D Pharmacy Benefits (Tables)          HTML     39K 
35: R28         Medical Costs Reserve Development (Tables)          HTML     36K 
34: R29         Commercial Paper and Long-Term Debt (Tables)        HTML    241K 
38: R30         Shareholders' Equity (Tables)                       HTML     32K 
39: R31         Share-Based Compensation (Tables)                   HTML    112K 
41: R32         Segment Financial Information (Tables)              HTML    321K 
22: R33         Business Combination (Details)                      HTML     60K 
71: R34         Business Combination Acquired Assets and            HTML     43K 
                Liabilities (Details)                                            
48: R35         Business Combination Acquired finite-lived          HTML     35K 
                intangible assets (Details)                                      
51: R36         Goodwill and Other Intangible Assets Goodwill       HTML     44K 
                Rollforward (Details)                                            
27: R37         Goodwill and Other Intangible Assets Future         HTML     35K 
                Amortization Expense relating to Intangible Assets               
                (Details)                                                        
83: R38         Investments (Narrative) (Details)                   HTML     28K 
16: R39         Investments (Short-Term and Long-Term Investments)  HTML     92K 
                (Details)                                                        
42: R40         Investments (Amortized Cost and Fair Value of       HTML     71K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
77: R41         Investments (Amortized Cost and Fair Value of       HTML     57K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
26: R42         Investments (Fair Value of Available-For-Sale       HTML     69K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
33: R43         Investments (Net Realized Gains) (Details)          HTML     51K 
37: R44         Fair Value (Narrative) (Details)                    HTML     50K 
45: R45         Fair Value (Financial Assets and Liabilities,       HTML     92K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
21: R46         Fair Value (Financial Assets and Liabilities,       HTML     86K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
30: R47         Fair Value (Reconciliation of Assets Measured at    HTML     50K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
18: R48         Fair Value Fair Value Inputs Assets Quantitative    HTML     45K 
                Information (Details)                                            
76: R49         Fair Value (Assets and Liabilities measured at      HTML    108K 
                fair value on a recurring basis) (Details)                       
25: R50         Medicare Part D Pharmacy Benefits Schedule of       HTML     33K 
                Receivables and Payables (Details)                               
73: R51         Medical Costs Reserve Development (Details)         HTML     29K 
28: R52         Health Insurance Industry Tax (Details)             HTML     29K 
43: R53         Commercial Paper and Long-Term Debt (Narrative)     HTML     73K 
                (Details)                                                        
17: R54         Commercial Paper and Long-Term Debt (Details)       HTML    179K 
20: R55         Commercial Paper and Long-Term Debt Fair Value      HTML     38K 
                Hedges Statement of Financial Position Location                  
                (Details)                                                        
36: R56         Commercial Paper and Long-Term Debt Fair Value      HTML     38K 
                Hedges Effect of Changes in Fair Value Hedges on                 
                Income (Details)                                                 
23: R57         Shareholders' Equity (Details)                      HTML     35K 
80: R58         Shareholders' Equity Dividends Paid (Details)       HTML     30K 
47: R59         Share-based Compensation Narrative (Details)        HTML     30K 
64: R60         Share-Based Compensation (Stock Option and SAR      HTML     72K 
                Activity) (Details)                                              
29: R61         Share-Based Compensation (Restricted Share          HTML     43K 
                Activity) (Details)                                              
32: R62         Share-Based Compensation Other Share-Based          HTML     53K 
                Compensation Data (Details)                                      
70: R63         Share-Based Compensation (Share-Based Compensation  HTML     46K 
                Principal Fair Value Assumptions) (Details)                      
68: R64         Commitments and Contingencies (Details)             HTML     40K 
49: R65         Segment Financial Information (Narrative)           HTML     32K 
                (Details)                                                        
69: R66         Segment Financial Information (Details)             HTML    114K 
82: XML         IDEA XML File -- Filing Summary                      XML    149K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX     91K 
10: EX-101.INS  XBRL Instance -- unh-20150930                        XML   5.30M 
12: EX-101.CAL  XBRL Calculations -- unh-20150930_cal                XML    240K 
13: EX-101.DEF  XBRL Definitions -- unh-20150930_def                 XML   1.07M 
14: EX-101.LAB  XBRL Labels -- unh-20150930_lab                      XML   1.88M 
15: EX-101.PRE  XBRL Presentations -- unh-20150930_pre               XML   1.23M 
11: EX-101.SCH  XBRL Schema -- unh-20150930                          XSD    184K 
72: ZIP         XBRL Zipped Folder -- 0000731766-15-000049-xbrl      Zip    316K

‘EX-101.SCH’ — XBRL Schema — unh-20150930

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.uhc.com/20150930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:unh="http://www.uhc.com/20150930" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-roles-2015-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20150930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20150930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20150930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20150930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="BasisOfPresentationNotes" roleURI="http://www.uhc.com/role/BasisOfPresentationNotes">

<link:definition> 2117100 - Disclosure - Basis of Presentation (Notes) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>